A meta-analysis of CSF fms-related tyrosine kinase 3 ligand (Flt3 ligand) revealed that MSA and PD patients had similar levels of Flt3 ligand (SMD = −0.50, 95% CI: -1.48 to 0.48) (Figure S3). This evidence concerns the gene FLT3LG and multiple system atrophy.